Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...
Officials say there are still a number of people in the hospital. Their fear is that the death toll could rise.
The University of Medical Center hosted hands-on surgery simulation workshops Saturday morning to nearly 30 high school students from underrepresented backgrounds who are interested in learning more ...